bioRxivBiochemistry
Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain
C. Wu, A. J. Qavi, A. Hachim, N. Kavian, A. R. Cole, A. B. Moyle, N. D. Wagner, J. Sweeney-Gibbons, H. W. Rohrs, M. L. Gross, J. S. M. Peiris, C. F. Basler, C. W. Farnsworth, S. A. Valkenburg, G. K. Amarasinghe, D. W. Leung
Abstract
Nucleocapsid protein (N) is the most abundant viral protein encoded by SARS-CoV-2, the causative agent of COVID-19. N plays key roles at different steps in the replication cycle and is used as a serological marker of infection. Here we characterize the biochemical properties of SARS-CoV-2 N. We define the N domains important for oligomerization and RNA binding that are associated with spherical droplet formation and suggest that N accessibility and assembly may be regulated by phosphorylation. We also map the RNA binding interface using hydrogen-deuterium exchange mass spectrometry. Finally, we find that the N protein C-terminal domain is the most immunogenic by sensitivity, based upon antibody binding to COVID-19 patient samples from the US and Hong Kong. Together, these findings uncover domain-specific insights into the significance of SARS-CoV-2 N and highlight the diagnostic value of using N domains as highly specific and sensitive markers of COVID-19.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proteoforms of the SARS-CoV-2 nucleocapsid protein are primed to proliferate the virus and attenuate the antibody response
Corinne A. Lutomski, Tarick J. El‐Baba, … Carol V. Robinson·bioRxiv·Oct 6, 2020
- Mapping SARS-CoV-2 Nucleocapsid Function with Nanobodies
Jules B. Weinstein, Timothy A. Bates, … Fikadu Tafesse·bioRxiv·Jan 27, 2026
- RNA structure and multiple weak interactions balance the interplay between RNA binding and phase separation of SARS-CoV-2 nucleocapsid
A. B. Estelle, H. M. Forsythe, … E. J. Barbar·bioRxiv·Jul 2, 2023
- SARS-CoV-2 Nucleocapsid protein is decorated with multiple N- and O-glycans.
N. T. Supekar, A. Shajahan, … P. Azadi·bioRxiv·Aug 26, 2020
- Structural dynamics of SARS-CoV-2 nucleocapsid protein induced by RNA binding
H. V. Ribeiro-Filho, G. E. Jara, … P. S. Lopes-de-Oliveira·bioRxiv·Aug 27, 2021
- Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
D. C. Dinesh, D. Chalupska, … E. Boura·bioRxiv·Apr 2, 2020